Pediatric Diabetes
Severe DKA at type 1 diabetes diagnosis doubles during pandemic
The incidence of severe diabetic ketoacidosis among children presenting with new-onset type 1 diabetes doubled during the COVID-19 pandemic period compared with data from 2019, according to data published in Pediatric Diabetes.
Overweight compounds likelihood of type 1 diabetes for children with high genetic risk
Children with a high genetic risk for developing type 1 diabetes are at an increased risk for the disease if they have overweight or obesity from age 2 to 10 years, according to trial data published in Diabetologia.
Hybrid closed-loop system poses no increased burden for children with type 1 diabetes
Children with type 1 diabetes using a hybrid closed-loop system and their parents do not report an increase in diabetes-related burden compared with those using a sensor-augmented insulin pump, according to trial data.
Emerging adults need focus, flexibility in transition from pediatric diabetes care
Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with diabetes care and education specialist and postdoctoral research fellow Julia Blanchette, PhD, RN, CDCES, about the transition from pediatric to adult diabetes care and the challenges for emerging adults living with diabetes.
Children use CGM more often when allowed to participate in treatment decisions
Children and adolescents with type 1 diabetes use continuous glucose monitoring for more days and have greater confidence when their parents involve them in the decision to initiate the device, according to a study published in Diabetes Care.
Access to uninterrupted CGM crucial for publicly insured children with type 1 diabetes
Children with public health insurance may commonly face harmful insurance-related interruptions of continuous glucose monitoring that are not reversed when access is restored, according to a study published in Pediatric Diabetes.
Preparation, technology key to managing diabetes in schools during pandemic
As the start of the new school year quickly approaches in the United States, parents of children with diabetes are trying to figure out how their child’s needs will be met when classes begin.
Top in endocrinology: Dapagliflozin, new integrated continuous glucose monitor
New data from the DAPA-HF trial showed that dapagliflozin was associated with a 32% lower risk for new-onset type 2 diabetes among patients with heart failure. It was the top story in endocrinology last week.
Children’s Hospital of Philadelphia tops pediatric diabetes, endocrinology rankings
Children’s Hospital of Philadelphia was once again named the No. 1 hospital in the country for pediatric diabetes and endocrinology by the U.S. News & World Report 2020-2021 Best Children’s Hospitals rankings.
Pediatric CGM use improves sleep quality for children, not parents in type 1 diabetes
A small study of young children with type 1 diabetes and their parents suggests that continuous glucose monitoring technology may improve a child’s sleep by minimizing wake periods during the night for blood glucose monitoring, whereas a parent’s sleep may be more disrupted by frequent nighttime blood glucose checks when using CGM, according to findings published in Diabetes Technology & Therapeutics.